Shunfeng Hu

537 total citations
39 papers, 332 citations indexed

About

Shunfeng Hu is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Shunfeng Hu has authored 39 papers receiving a total of 332 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Molecular Biology, 11 papers in Oncology and 10 papers in Immunology. Recurrent topics in Shunfeng Hu's work include RNA modifications and cancer (9 papers), Immune Cell Function and Interaction (7 papers) and Lymphoma Diagnosis and Treatment (7 papers). Shunfeng Hu is often cited by papers focused on RNA modifications and cancer (9 papers), Immune Cell Function and Interaction (7 papers) and Lymphoma Diagnosis and Treatment (7 papers). Shunfeng Hu collaborates with scholars based in China, United States and Canada. Shunfeng Hu's co-authors include Xin Wang, Xiangxiang Zhou, Yiqing Cai, Jiarui Liu, Yi Zhao, Shuai Ren, Yang Han, Juan Yang, Xiaohong Chen and Wenyue Sun and has published in prestigious journals such as Blood, Journal of Materials Chemistry A and British Journal of Cancer.

In The Last Decade

Shunfeng Hu

37 papers receiving 331 citations

Peers

Shunfeng Hu
Hanzhang Zhu China
Markus Linder Austria
Christine Pich-Bavastro Switzerland
Manu Prasad Israel
Sandipto Sarkar United States
Changku Jia China
Jeannette Huaman United States
Saima Usman United Kingdom
Liping Fan China
Hanzhang Zhu China
Shunfeng Hu
Citations per year, relative to Shunfeng Hu Shunfeng Hu (= 1×) peers Hanzhang Zhu

Countries citing papers authored by Shunfeng Hu

Since Specialization
Citations

This map shows the geographic impact of Shunfeng Hu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shunfeng Hu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shunfeng Hu more than expected).

Fields of papers citing papers by Shunfeng Hu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shunfeng Hu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shunfeng Hu. The network helps show where Shunfeng Hu may publish in the future.

Co-authorship network of co-authors of Shunfeng Hu

This figure shows the co-authorship network connecting the top 25 collaborators of Shunfeng Hu. A scholar is included among the top collaborators of Shunfeng Hu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shunfeng Hu. Shunfeng Hu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhou, Xiaoli, Qianqian Guo, Xiaosheng Fang, et al.. (2025). Magnolin Promotes PINK1-Parkin-mediated Mitophagy in Diffuse Large B-cell Lymphoma Cells via PPAR-γ Pathway. Phytomedicine. 145. 157059–157059.
2.
Hu, Shunfeng, et al.. (2025). Highly Transparent Anti-Smudge Coatings for Self-Cleaning, Controllable Liquid Transport, and Corrosion Resistance. Polymers. 17(3). 302–302. 1 indexed citations
3.
Liu, Bingyu, Xiaoli Zhou, Xiaosheng Fang, et al.. (2025). Decipherment of disulfidptosis-related mutation profile, chemosensitivity, and prognosis in diffuse large B-cell lymphoma. Journal of Molecular Medicine. 103(11-12). 1387–1403. 1 indexed citations
4.
Hu, Shunfeng, et al.. (2025). Recent advances in oncolytic virus combined immunotherapy in tumor treatment. Genes & Diseases. 12(6). 101599–101599. 4 indexed citations
5.
Sun, Wenyue, Shunfeng Hu, & Xin Wang. (2024). Advances and clinical applications of immune checkpoint inhibitors in hematological malignancies. Cancer Communications. 44(9). 1071–1097. 15 indexed citations
6.
Hu, Shunfeng, et al.. (2024). The regulatory roles and clinical significance of glycolysis in tumor. Cancer Communications. 44(7). 761–786. 30 indexed citations
7.
8.
Liu, Bingyu, Shunfeng Hu, & Xin Wang. (2024). Applications of single-cell technologies in drug discovery for tumor treatment. iScience. 27(8). 110486–110486. 6 indexed citations
9.
Sun, Wenyue, Shunfeng Hu, & Xin Wang. (2024). Update of antibody–drug conjugates for hematological malignancies. Current Opinion in Oncology. 36(5). 430–436. 3 indexed citations
10.
Cai, Yiqing, Xiaohong Chen, Shunfeng Hu, et al.. (2023). Single-cell transcriptome analysis profiles the expression features of TMEM173 in BM cells of high-risk B-cell acute lymphoblastic leukemia. BMC Cancer. 23(1). 372–372. 4 indexed citations
11.
Hu, Shunfeng, et al.. (2023). PGD2 displays distinct effects in diffuse large B-cell lymphoma depending on different concentrations. Cell Death Discovery. 9(1). 39–39. 3 indexed citations
12.
Chen, Xiaohong, Shunfeng Hu, Yang Han, et al.. (2023). Ferroptosis-related STEAP3 acts as predictor and regulator in diffuse large B cell lymphoma through immune infiltration. Clinical and Experimental Medicine. 23(6). 2601–2617. 15 indexed citations
13.
Hu, Shunfeng, et al.. (2023). Recent advances of ferroptosis in tumor: From biological function to clinical application. Biomedicine & Pharmacotherapy. 166. 115419–115419. 16 indexed citations
14.
Ge, Xueling, Ying Li, Yiqing Cai, et al.. (2023). Derivation and validation of a nutrition-covered prognostic scoring system for extranodal NK/T-cell lymphoma. Frontiers in Nutrition. 10. 1080181–1080181. 2 indexed citations
15.
Zhao, Yi, Juan Yang, Jiarui Liu, et al.. (2021). Inhibition of Polo-like kinase 4 induces mitotic defects and DNA damage in diffuse large B-cell lymphoma. Cell Death and Disease. 12(7). 640–640. 18 indexed citations
16.
Hu, Shunfeng, Shuai Ren, Yiqing Cai, et al.. (2021). Glycoprotein PTGDS promotes tumorigenesis of diffuse large B-cell lymphoma by MYH9-mediated regulation of Wnt–β-catenin–STAT3 signaling. Cell Death and Differentiation. 29(3). 642–656. 70 indexed citations
17.
Shi, Lei, Yiqing Cai, Shunfeng Hu, et al.. (2021). Derivation and validation of a lipid-covered prognostic model for mature T-cell lymphomas. Cancer Cell International. 21(1). 348–348. 5 indexed citations
18.
Liu, Xiaoqian, Xiaomei Li, Yahan Li, et al.. (2021). Risk Stratification for Diffuse Large B-Cell Lymphoma by Integrating Interim Evaluation and International Prognostic Index: A Multicenter Retrospective Study. Frontiers in Oncology. 11. 754964–754964. 7 indexed citations
19.
20.
Liu, Jiarui, Yang Han, Shunfeng Hu, et al.. (2021). Circulating Exosomal MiR-107 Restrains Tumorigenesis in Diffuse Large B-Cell Lymphoma by Targeting 14-3-3η. Frontiers in Cell and Developmental Biology. 9. 667800–667800. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hanzhang Zhu Breakdown of academic impact, for papers by Markus Linder Breakdown of academic impact, for papers by Christine Pich-Bavastro Breakdown of academic impact, for papers by Manu Prasad Breakdown of academic impact, for papers by Sandipto Sarkar Breakdown of academic impact, for papers by Changku Jia Breakdown of academic impact, for papers by Jeannette Huaman Breakdown of academic impact, for papers by Saima Usman Breakdown of academic impact, for papers by Liping Fan
Rankless by CCL
2026